Reports By Brokerage: SMIFS
PSP Projects has a sturdy foundation & promising future prospects. Buy for target price of Rs 905: SMIFS | |
Company: | PSP Projects Ltd |
Brokerage: | SMIFS |
Date of report: | November 24, 2023 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 20% |
Summary: | Additionally, well-managed balance sheet, strict working capital controls, and healthy return ratios are added positives. Given the favourable outlook, we initiate coverage with a Target Price of Rs905/share (15x Sept’25 estimated EPS), representing an upside potential of ~20% |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: SMIFS
Gabriel India Ltd is favourably positioned as key clients in ICE & EV gaining market share! Buy for target price of Rs 341 (20% upside): SMIFS | |
Company: | Gabriel India Ltd |
Brokerage: | SMIFS |
Date of report: | November 3, 2023 |
Type of Report: | Result Update |
Recommendation: | Buy |
Upside Potential: | 20% |
Summary: | We are strongly convinced of the company’s competitive position, and is well placed for the mid-to-long term growth opportunities. It’s a debt-free and has always generated positive cash flows in the last 11 years |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: SMIFS
We are strongly convinced on Gabriel India’s competitive position, key clients, market share. Buy for target price of Rs 409 (27% upside) | |
Company: | Gabriel India Ltd |
Brokerage: | SMIFS |
Date of report: | October 23, 2023 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 27% |
Summary: | We trust Gabriel has a very promising future on account of 1) benefits due to sustained demand recovery in the coming years across automobile segments, 2) well-diversified product portfolio, 3) key customers gaining share, 4) winning new orders from electric vehicle OEMs, 5) steady revenue growth visibility into the aftermarket sales, 6) entering into high growth, better margin products viz. automotive sunroof, and we anticipate further introduction of new technology agnostic products to drive growth higher than the industry |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: SMIFS
Divi’s Laboratories Ltd is strategically poised to capitalize on emerging opportunities. Buy for target price Rs 4041: SMIFS | |
Company: | Divi's Lab |
Brokerage: | SMIFS |
Date of report: | August 14, 2023 |
Type of Report: | Result Update |
Recommendation: | Buy |
Upside Potential: | 8.3% |
Summary: | Divi is strategically poised to capitalize on emerging opportunities presented by recently off-patent molecules. Company is seeing softening of RM and logistics costs which will improve the margins further. We forecast Revenue / EBITDA / PAT CAGR during FY23- 25E at 16.7%/31.5%/27.5%. We value the stock based on SOTP valuation strategy and arrive at a target price of INR 4,041. Accumulate |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: SMIFS
S.J.S. Enterprises Ltd (Ashish Kacholia Portfolio Stock) has clean & clear visible growth triggers. Buy for TP of Rs 593 (+33%): SMIFS | |
Company: | S.J.S. Enterprises |
Brokerage: | SMIFS |
Date of report: | January 30, 2023 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 33% |
Summary: | We are of the opinion that SJS at ease will be able to achieve PAT growth @18% CAGR FY22-FY25e with sustainable margin of about 25%+ level. Over & above, the team is aggressively hunting for inorganic acquisition, which can add a new wing in either technology, futuristic products, markets and/or customers |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: SMIFS
KIMS is steadily building its empire by conquering and ruling. Buy for target price of Rs 1682 (18% upside) | |
Company: | KIMS, Krishna Institute Of Medical Sciences |
Brokerage: | SMIFS |
Date of report: | January 23, 2023 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 18% |
Summary: | Currently, the stock is trading at comforting valuation on FY25E EV/EBITDA of 15x. We value the stock at 20x (in line with its historical average) due to capacity and geographical expansion, improved margins and robust revenue growth, thereby, arrive at target price of Rs 1,682 per share which offers upside of 18% from current valuations. Therefore, we assign BUY rating on the stock. |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: SMIFS
Supreme Petrochem has very strong business model. Buy for target price of Rs 561 (51% upside): SMIFS | |
Company: | Supreme Petrochem |
Brokerage: | SMIFS |
Date of report: | January 19, 2023 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 51% |
Summary: | Supreme Petrochem (SPL) has very strong business model in Polystyrene (PS) & Expandable Polystyrene (EPS) along with its downstream derivatives like XPS & SPC. The company is expanding its capacity in all business segments viewing the growth opportunities available post closure of business of its nearest competitor in India, increasing demand growth & strong balance sheet to fund capital expenditure. |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: SMIFS
Indoco Remedies is an attractive investment proposition. Buy for target price of Rs 469 (24% upside): SMIFS | |
Company: | indoco remedies |
Brokerage: | SMIFS |
Date of report: | December 23, 2022 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 24% |
Summary: | Strong business fundamentals such as diversified segments mix and strong product portfolio along with high return ratios make Indoco an attractive investment proposition |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: SMIFS
PCBL Ltd is a carbon black giant, set to grow at a fast clip. Buy for 35% upside: SMIFS | |
Company: | PCBL |
Brokerage: | SMIFS |
Date of report: | December 18, 2022 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 35% |
Summary: | Currently, the stock is trading at inexpensive valuation on FY25E P/E of ~9.3x. We value the stock on forward P/E multiple of 12.5x owing to increasing share of speciality business, robust volume growth & rising exports share and, thereby, arrive at target price of Rs 183 per share which offers upside of 35% from current valuations. |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: SMIFS
Four Stock Recommendations For December By SMIFS | |
Company: | Model Portfolio |
Brokerage: | SMIFS |
Date of report: | December 2, 2022 |
Type of Report: | Techno-Funda |
Recommendation: | Buy |
Upside Potential: | 66% |
Summary: | SMIFS has recommended four stocks to buy with good risk-reward ratios. |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |